Cargando…
Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288385/ http://dx.doi.org/10.1186/2051-1426-2-S3-P103 |
| _version_ | 1782351960848990208 |
|---|---|
| author | Hodi, F Stephen Ribas, Antoni Daud, Adil Hamid, Omid Robert, Caroline Kefford, Richard Hwu, Wen-Jen Gangadhar, Tara C Joshua, Anthony M Hersey, Peter Weber, Jeffrey Joseph, Richard W Zarour, Hassane Dronca, Roxana Gammage, Linda Hille, Darcy Xue, Dahai Kang, S Peter Chun, Patrick Ebbinghaus, Scot W Perrone, Andrea Wolchok, Jedd D |
| author_facet | Hodi, F Stephen Ribas, Antoni Daud, Adil Hamid, Omid Robert, Caroline Kefford, Richard Hwu, Wen-Jen Gangadhar, Tara C Joshua, Anthony M Hersey, Peter Weber, Jeffrey Joseph, Richard W Zarour, Hassane Dronca, Roxana Gammage, Linda Hille, Darcy Xue, Dahai Kang, S Peter Chun, Patrick Ebbinghaus, Scot W Perrone, Andrea Wolchok, Jedd D |
| author_sort | Hodi, F Stephen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288385 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42883852015-01-15 Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC) Hodi, F Stephen Ribas, Antoni Daud, Adil Hamid, Omid Robert, Caroline Kefford, Richard Hwu, Wen-Jen Gangadhar, Tara C Joshua, Anthony M Hersey, Peter Weber, Jeffrey Joseph, Richard W Zarour, Hassane Dronca, Roxana Gammage, Linda Hille, Darcy Xue, Dahai Kang, S Peter Chun, Patrick Ebbinghaus, Scot W Perrone, Andrea Wolchok, Jedd D J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288385/ http://dx.doi.org/10.1186/2051-1426-2-S3-P103 Text en Copyright © 2014 Hodi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Hodi, F Stephen Ribas, Antoni Daud, Adil Hamid, Omid Robert, Caroline Kefford, Richard Hwu, Wen-Jen Gangadhar, Tara C Joshua, Anthony M Hersey, Peter Weber, Jeffrey Joseph, Richard W Zarour, Hassane Dronca, Roxana Gammage, Linda Hille, Darcy Xue, Dahai Kang, S Peter Chun, Patrick Ebbinghaus, Scot W Perrone, Andrea Wolchok, Jedd D Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC) |
| title | Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC) |
| title_full | Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC) |
| title_fullStr | Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC) |
| title_full_unstemmed | Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC) |
| title_short | Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC) |
| title_sort | patterns of response in patients with advanced melanoma treated with pembrolizumab (mk-3475) and evaluation of immune-related response criteria (irrc) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288385/ http://dx.doi.org/10.1186/2051-1426-2-S3-P103 |
| work_keys_str_mv | AT hodifstephen patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT ribasantoni patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT daudadil patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT hamidomid patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT robertcaroline patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT keffordrichard patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT hwuwenjen patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT gangadhartarac patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT joshuaanthonym patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT herseypeter patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT weberjeffrey patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT josephrichardw patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT zarourhassane patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT droncaroxana patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT gammagelinda patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT hilledarcy patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT xuedahai patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT kangspeter patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT chunpatrick patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT ebbinghausscotw patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT perroneandrea patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc AT wolchokjeddd patternsofresponseinpatientswithadvancedmelanomatreatedwithpembrolizumabmk3475andevaluationofimmunerelatedresponsecriteriairrc |